🇺🇸 FDA

Company profile · Sponsor

Sichuan

Sichuan Baili Pharmaceutical Co.,

CD68D3A · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Sichuan (CD68D3A) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CD68D3A
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. BL-B01D1

    Sichuan

    Cervical Cancer

    phase 2 small molecule active

    1 trial

  2. BL-B01D1

    Sichuan

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  3. SI-B001

    Sichuan

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  4. BL-M07D1

    Sichuan

    Breast Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Sichuan?

Sichuan (CD68D3A) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Sichuan sponsor?

We track 4 ClinicalTrials.gov-linked programs for Sichuan, including BL-B01D1 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sichuan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.